Table 1 Baseline characteristics of individuals stratified by tertiles of TG/HDL-C ratio
Variables | Total | TG/HDL-C ratio | P value | ||
|---|---|---|---|---|---|
T1 ≤ 0.833 (n = 323) | 0.833 < T2 ≤ 1.496 (n = 325) | T3 > 1.496 (n = 325) | |||
Age (y) | 49.67 ± 14.58 | 50.95 ± 15.09 | 49.55 ± 14.18 | 48.52 ± 14.41 | 0.103 |
Male (%) | 556 (57.1) | 198 (61.3) | 172 (52.9) | 186 (57.2) | 0.098 |
Body mass index (kg/m 2) | 21.91 ± 3.34 | 21.17 ± 2.93 | 21.83 ± 3.31 | 22.73 ± 3.58 | < 0.001 |
Diabetes (%) | 186 (19.1) | 59 (18.3) | 61 (18.8) | 66 (20.3) | 0.789 |
CVD (%) | 96 (9.9) | 28 (8.7) | 27 (8.3) | 41 (12.6) | 0.124 |
Hypertension (%) | 710 (73) | 223 (69) | 254 (78.2) | 233 (71.7) | 0.027 |
Systolic pressure (mmHg) | 146.91 ± 25.89 | 147.48 ± 25.57 | 146.96 ± 24.99 | 146.28 ± 27.14 | 0.84 |
Diastolic pressure (mmHg) | 87.91 ± 15.89 | 87.34 ± 16.44 | 88.42 ± 14.29 | 87.96 ± 16.62 | 0.683 |
CCI | 3.53 ± 1.88 | 3.60 ± 1.87 | 3.48 ± 1.85 | 3.51 ± 1.92 | 0.711 |
Total Kt/V | 2.16 (1.67, 2.70) | 2.15 (1.51, 2.60) | 2.20 (1.73, 2.72) | 2.09 (1.68, 2.74) | 0.131 |
eGFR (ml/min per 1.73 m 2) | 3.19 (1.73, 5.50) | 2.90 (1.69, 4.76) | 3.16 (1.71, 5.56) | 3.55 (1.77, 5.82) | 0.16 |
White blood cells (/L) | 5.74 (4.50, 7.21) | 5.33 (4.22, 6.90) | 5.73 (4.43, 6.95) | 6.15 (4.97, 7.73) | < 0.001 |
Hemoglobin (g/L) | 78.89 ± 16.81 | 76.71 ± 14.83 | 78.96 ± 16.98 | 80.98 ± 19.0 | 0.005 |
Platelet (/L) | 161.0 (118.0, 206.5) | 151.0 (111.0, 192.0) | 158.0 (112.0, 206.25) | 176.0 (129.0, 220.25) | < 0.001 |
Albumin (g/L) | 35.41 ± 5.25 | 35.56 ± 5.06 | 35.39 ± 5.41 | 35.28 ± 5.28 | 0.798 |
uric acid (mmol/L) | 435 (347, 535) | 428.5 (342.50, 520.75) | 441.5 (356, 540) | 439 (345, 562) | 0.314 |
Total cholesterol (mmol/L) | 4.06 (3.37, 4.85) | 3.99 (3.23, 4.65) | 4.04 (3.37, 4.82) | 4.22 (3.49, 5.12) | 0.005 |
Triglycerides (mmol/L) | 1.27 (0.89, 1.76) | 0.80 (0.63, 0.96) | 1.26 (1.03, 1.48) | 2.06 (1.69, 2.57) | < 0.001 |
HDL-C (mmol/L) | 1.09 (0.90, 1.39) | 1.40 (1.18, 1.69) | 1.09 (0.95, 1.31) | 0.88 (0.73, 1.03) | < 0.001 |
Lipid-lowering agents use (%) | 91 (9.4) | 23 (7.1) | 23 (7.1) | 45 (13.8) | 0.003 |